Medibank Private Statistics
Want to see AU:MPL full AI Analyst Report?
Medibank Private (MPL) Stock Statistics & Valuation Metrics
Total Valuation
Medibank Private has a market cap or net worth of AUD 14.87B. The enterprise value is AUD 13.94B.
- Market Cap
- AUD 14.87B
- Enterprise Value
- AUD 13.94B
Share Statistics
Medibank Private has 2,754,003,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,754,003,200
- Owned by Insiders
- <0.01%
- Owned by Institutions
- 17.29%
Financial Efficiency
Medibank Private’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 13.49%.
- Return on Equity (ROE)
- 0.26
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 13.49%
- Return on Capital Employed (ROCE)
- 0.20
- Revenue Per Employee
- 1.86M
- Profits Per Employee
- 127.71K
- Employee Count
- 5,001
- Asset Turnover
- 1.96
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Medibank Private is 23.48. Medibank Private’s PEG ratio is 0.85.
- PE Ratio
- 23.48
- PS Ratio
- 1.59
- PB Ratio
- 6.12
- Price to FCF
- 24.66
- Price to Operating Cash Flow
- 23.89
- PEG Ratio
- 0.85
Income Statement
In the last 12 months, Medibank Private had revenue of 9.33B and earned 638.70M in profits. Earnings per share was 0.23.
- Revenue
- 9.33B
- Gross Profit
- 1.60B
- Operating Income
- 927.90M
- Pretax Income
- 927.90M
- Net Income
- 638.70M
- EBITDA
- 1.05B
- Earnings Per Share (EPS)
- 0.23
Cash Flow
In the last 12 months, operating cash flow was 622.50M and capital expenditures -19.40M, giving a free cash flow of 603.10M billion.
- Operating Cash Flow
- 622.50M
- Free Cash Flow
- 603.10M
- Free Cash Flow per Share
- 0.22
Dividends & Yields
Medibank Private pays an annual dividend of AUD 0.08, resulting in a dividend yield of 3.56%
- Dividend Per Share
- AUD 0.08
- Dividend Yield
- 3.56%
- Payout Ratio
- 82.59%
- Free Cash Flow Yield
- 4.06%
- Earnings Yield
- 4.29%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- 11.11%
- 50-Day Moving Average
- 4.78
- 200-Day Moving Average
- 4.66
- Relative Strength Index (RSI)
- 73.48
- Average Volume (3m)
- 7.41M
Important Dates
Medibank Private upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 19, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- Feb 25, 2026
Financial Position
Medibank Private as a current ratio of 0.00, with Debt / Equity ratio of 11.27%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.28
- Interest Coverage Ratio
- 58.73
Taxes
In the past 12 months, Medibank Private has paid 281.60M in taxes.
- Income Tax
- 281.60M
- Effective Tax Rate
- 0.30
Enterprise Valuation
Medibank Private EV to EBITDA ratio is 15.44, with an EV/FCF ratio of 24.17.
- EV to Sales
- 1.56
- EV to EBITDA
- 15.44
- EV to Free Cash Flow
- 24.17
- EV to Operating Cash Flow
- 23.41
Balance Sheet
Medibank Private has AUD 570.40M in cash and marketable securities with AUD 273.90M in debt, giving a net cash position of AUD 296.50M billion.
- Cash & Marketable Securities
- AUD 570.40M
- Total Debt
- AUD 273.90M
- Net Cash
- AUD 296.50M
- Net Cash Per Share
- AUD 0.11
- Tangible Book Value Per Share
- AUD 0.63
Margins
Gross margin is 58.53%, with operating margin of 9.95%, and net profit margin of 6.85%.
- Gross Margin
- 58.53%
- Operating Margin
- 9.95%
- Pretax Margin
- 9.95%
- Net Profit Margin
- 6.85%
- EBITDA Margin
- 10.12%
- EBIT Margin
- 10.12%
Analyst Forecast
The average price target for Medibank Private is AUD 5.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- AUD 5.13
- Price Target Upside
- 5.03% Downside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 7
- Revenue Growth Forecast
- 9.29%
- EPS Growth Forecast
- 27.49%
Scores
- Smart Score
- 9
- AI Score
- 66

